undefined,undefined,China China
In ***7, the company successfully obtained A round of financing, and invested in the establishment of A wholly-owned subsidiary, Jiangsu Aoya biotechnology co., ltd. in China pharmaceutical city, to comprehensively upgrade the research and development center and production base. At present, the company has 8,**0 square meters of production and development site, 1,**0 square meters of GMP workshop, more than *0 core patents authorized, more than *0 product registration certificates, the products have been sold to more than 5,**0 medical institutions in more than *0 provinces.
Type d'entreprise
Manufacturing
Site web
www.pro-med.com.cn
Année de création
2013
Number of Employees
101-500
Marchés principaux
Worldwide
Produits / services de la société
covid 19 antibody test kit
Emplacement d'usine
Changping, Beijing, China
Taille d'usine
5000 sqm to 10000 sqm
Nombre de lignes de production
8
Volume total des achats annuels
1 - 2.5 Million USD
Nb de personnel de R & D
11 - 20 people
Contrôle de la qualité
In House
Certificat
ISO13485:2016
Fabrication àfaçon
OEM Service Offered ,Buyer Label Offered
Capital enregistré
1 - 2.5 Million USD
Ownership Type
Corporation Limited Liability Company
Représentant / Directeur juridique
Zhanjiang Yu
Pourcentage d'exportation
20%
Volume total des ventes annuelles
2.5 - 10 Million USD
Nb de personnel QC
11 - 20 people
Personne àcontacter
Lexy Wu
Société
Pro-med (Beijing) Technology Co., Ltd.
Nom de la société
undefined, undefined, China
Personne àcontacter Lexy Wu
Nom de la société undefined, undefined, China
